A Hybrid Effectiveness-implementation Evaluation on Programs Promoting Healthy Aging With Sport Exercise (PHASE Program)
Launched by THE UNIVERSITY OF HONG KONG · Oct 13, 2023
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
The PHASE Program clinical trial is studying how different types of exercise can help older adults stay healthy and improve their daily functioning. Participants who are 60 years or older will be invited to take part in this study. They will be divided into groups where some will participate in specific exercise programs, such as football training, technology-assisted workouts, gentle sports, walking, or exercises they can do at home. There will also be a control group that will not receive any exercise intervention, which helps researchers compare the results.
If you or a family member is interested in joining, it's important to know that you must be over 60 years old and generally healthy enough to participate in exercise. This trial aims to evaluate both the physical and mental benefits of these targeted exercise programs. By taking part, you could help researchers understand how to promote healthy aging through physical activity, which could benefit many older adults in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age above 60 years
- Exclusion Criteria:
- • Any contraindication to exercise training
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Doris Sau Fung YU, PhD
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported